About FairPark II

About Fair Park II

What is FAIR PARK II? What is Parkinson’s Disease? What is iron chelation?

Who is involved in Fair Park II?

Who?

Who is involved? Who are the patients? Can I get involved?

Fair Park II Progress

Progress

Find out how we are getting on with the study through our regular updates

News

The first patient has been enrolled at Lille's Hospital on February 9th 2016

The FAIR PARK II 4th annual meeting was held in Lisbon, Portugal on June 15th and 16th 2018

The FAIR PARK II 3rd annual meeting was held in Amsterdam, Netherlands on June 26th and 27th 2017

The FAIR PARK II 2nd annual meeting was held in Berlin, Germany on June 23rd and 24th 2016

The FAIR-PARK II kick-off meeting was held in Lille, France on 4-5 May 2015

 

The final list of European expert centres for the clinical trial will be available in October 2015

The final version of the study protocol, as submitting to regulators and ethics committees, will be available in January 2016.

Patient Recruitment Countdown

6th November 2019

Patients to be recruited

13

Patients recruited

359

FAIR PARK II

Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone

Latest News Articles

Go to top